BioCentury
ARTICLE | Company News

Response Genetics sales and marketing update

July 9, 2012 7:00 AM UTC

Response Genetics launched its EML4- ALK real-time PCR test to identify anaplastic lymphoma kinase (ALK) rearrangements in a sub-population of non-small cell lung cancer (NSCLC) patients who had nega...